In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
about
Artemisinin and a Series of Novel Endoperoxide Antimalarials Exert Early Effects on Digestive Vacuole MorphologyThe bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blueLarge-scale differential proteome analysis in Plasmodium falciparum under drug treatmentIsothermal microcalorimetry, a new tool to monitor drug action against Trypanosoma brucei and Plasmodium falciparumA novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparumCharacterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingHigh-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.Stage independent chloroquine resistance and chloroquine toxicity revealed via spinning disk confocal microscopy.Fixed dose combination of arterolane and piperaquine: a newer prospect in antimalarial therapyThe lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesComparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivaxSynthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria.Development and validation of a headspace gas chromatographic method for the determination of residual solvents in arterolane (RBx11160) maleate bulk drug.The global pipeline of new medicines for the control and elimination of malariaProfile of William C. Campbell, Satoshi Ōmura, and Youyou Tu, 2015 Nobel Laureates in Physiology or Medicine.Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel).A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and AfricaIn vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models.Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum.Emerging drugs for malaria.Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).A new double-antibody sandwich ELISA targeting Plasmodium falciparum aldolase to evaluate anti-malarial drug sensitivity.The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine.Compounds structurally related to ellagic acid show improved antiplasmodial activity.Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277).Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. falciparum malaria.Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts In Vitro Antimalarial Activity.
P2860
Q22061805-F6537835-D4B4-4E96-BCDB-AA01D4543A2DQ27672885-A1102D2F-BD2B-47F3-A07F-21A87AB58AD6Q28474424-2015BE69-D856-4B6C-AF31-26C5BFD95DC7Q28484117-9209B6D5-CFFA-4818-8103-F5EE01EE01FEQ28486811-11331137-6F75-4ED8-B513-74B7EB1884E2Q28554466-B6E2D018-D3F4-43A6-8DC5-FBFFDC52D95AQ30619647-7C031217-B8C9-4FAA-A055-425898C71C11Q33320129-F6C67A40-B24B-4984-A04D-F0C33B3E66B4Q34162314-98E24FD3-54EF-49CC-AE94-7CD03E4F15B5Q34329204-D594EAD3-6ECC-4A71-829A-ACE516BDA1F0Q34360576-6743B984-8188-46D4-8961-0565616648DBQ34693880-3693FDF4-75F3-44ED-B718-3EBFC435FFDAQ35135272-6E8983CD-7EBB-4C39-B91E-52EC71363548Q36320249-2F26A7F9-DB08-41CF-B413-BA28D897F602Q36435188-BF24A441-D2F8-41D2-B9E5-8E2C8A83DF6CQ36478925-7353C1F9-F93E-47FE-B0B5-4A3D645AD112Q36715829-FD252760-3657-446C-9965-5CAE9BEA05E6Q37320938-4AAEB109-345B-4BDE-967B-255806E50E08Q37348404-CF0474C4-98AE-4231-A13F-AEF1A32D74BEQ38027179-6ACE78F4-D5E8-4171-8555-7BBD75373AD0Q39115683-AEA8356E-89D8-4A05-BD16-C2D68E43B6A6Q39534318-4C0AB15F-9E75-4659-BD73-ABBA0D34B61DQ41928320-91A4E8F5-F4C4-42FD-A5EF-DED97CEBC9FCQ41939792-45FD582A-1DE7-4096-875F-C341375C291BQ42018084-1D58D888-5725-41D6-90D4-DB3332A4CF05Q47967717-241A0B66-DB1D-40AA-BEA3-F8E94A738CF8Q51771415-14277259-7839-4B55-9E96-86E1465F994B
P2860
In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
In vitro assessment of the pha ...... ures of Plasmodium falciparum.
@en
In vitro assessment of the pha ...... ures of Plasmodium falciparum.
@nl
type
label
In vitro assessment of the pha ...... ures of Plasmodium falciparum.
@en
In vitro assessment of the pha ...... ures of Plasmodium falciparum.
@nl
prefLabel
In vitro assessment of the pha ...... ures of Plasmodium falciparum.
@en
In vitro assessment of the pha ...... ures of Plasmodium falciparum.
@nl
P2093
P356
P1476
In vitro assessment of the pha ...... ures of Plasmodium falciparum.
@en
P2093
Arnulf Dorn
Hugues Matile
Sonja Maerki
Susan A Charman
P356
10.1093/JAC/DKL209
P407
P577
2006-05-30T00:00:00Z